Skip to main content

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant

Include preview-only content
  1. Article

    Open Access

    Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation

    Patients with newly diagnosed multiple myeloma (NDMM) ineligible for autologous stem cell transplantation (ASCT) have lower survival rates and may benefit from frontline regimens that include novel agents. Thi...

    Enrique M. Ocio, Aurore Perrot, Pierre Bories, Jesus F. San-Miguel in Leukemia (2023)

  2. Article

    Open Access

    Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

    Vaccination is one of the most successful medical interventions that has saved the life of millions of people. Vaccination is particularly important in patients with multiple myeloma, who have an increased ris...

    Heinz Ludwig, Mario Boccadoro, Philippe Moreau, Jesus San-Miguel, Michele Cavo in Leukemia (2021)